Barely Significant
← all excerpts

Serum advanced glycation end-products as a biomarker of cumulative glycaemic burden and complications in type 2 diabetes: a pilot study.

Ann Med · 2026 · PMC13195711 · PMID 42159221

2
hedged sentences
0.0010
closest p · 0.0× alpha
0.0370
boldest claim

The sentences

highly significantp < .001actually significant
The transition from uncomplicated to complicated diabetes remained highly significant ( p < .001, d = 0.802), indicating that complication development is accompanied by a substantial further acceleration in AGE accumulation (59.4% increase beyond uncomplicated T2DM).

also in 132,142 other papers

showed a trendp = .037actually significant
Compared with healthy controls (median 5.99 AU), AGEs showed a trend in impaired glucose tolerance (7.22 AU; Cohen’s d = 0.425; uncorrected p = .037, corrected p = .094), significant increases in uncomplicated diabetes (9.81 AU; d = 1.027, p < .001) and complicated diabetes (13.35 AU; d = 1.540, p < .001), with no elevation in isolated hyperlipidaemia (5.86 AU; p = .987).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.